Awardee OrganizationCOLUMBIA UNIVERSITY HEALTH SCIENCES
Description
Abstract Text
PROJECT 3: PROJECT SUMMARY/ABSTRACT
Urinary tract infections are the most common urogenital abnormality worldwide affecting multiple organs of the
urinary tract including the urethra, bladder, prostate, ureter, and kidney. To establish a urinary tract infection,
bacteria must obtain nutrients in order to undergo continuous replication. These nutrients derive from the urine
and the epithelia of the urinary tract. Iron is a “precious metal” for bacteria because metabolic processes including
energy production and cell division require ~100,000 atoms of iron per bacterium. Yet it is the most difficult
nutrient to obtain because the common form, called ferric iron, is insoluble in water (Ksp=10-12M). Gram-negative
organisms have devised methods to obtain iron even with these vanishing low concentrations. They do this by
the production of a series of small molecules known as siderophores, each with astronomical affinity for iron.
One type of siderophore, called Enterochelin is the most prevalent. Yet, the epithelial cells of the urogenital tract
recognize this threat and rapidly produce a protein called NGAL (Lcn2) in great abundance. NGAL captures
Ent:Fe and prevents its iron from reaching bacteria. We discovered that the urothelium and the tracts up into the
kidney expresses NGAL. While most of our studies have focused on NGAL:Ent:Fe, there must be alternative
nutrient pathways and alternative mammalian defenses. We propose that bacterial heme transporters also steal
our iron and that epithelia in turn capture and metabolize heme. By adapting a novel method to analyze
“snapshots” of nascent RNA, we found that bladder urothelia and collecting ducts express heme capture, heme
metabolism, and iron sequestration and transport proteins, which compete with bacteria for heme. Most intriguing
is our finding that upon infection, the urothelial “heme machine” is activated and releases a byproduct of heme
metabolism, called Carbon Monoxide, a bacteriostatic agent. Moreover, the heme machine is the core complex
of the Circadian Clock, which is regulated by CO. Here we test the basic tenets of our hypothesis. We carefully
document heme and iron transport and metabolism in the urothelium to test the notion of that the urothelium and
bacteria compete for heme. We suggest that these mechanisms are re-purposed for “nutritional immune
defense” from the daily defense against the lysis of RBC that traverse the bladder each day. To investigate these
mechanisms, we have invented novel methods of RNA isolation, imaging tools to detect bacterial responses, a
method to detect and capture CO in vivo, novel mouse ko’s, and bacteria isolated from our patients with UTI’s
carrying mutations in siderophore and heme pathways. We are working with a leading microbiologist
(Uhlemann), animal geneticist (Mendelsohn), UTI specialist (Mysorekar) and the leading scientist in heme
biology (Hamza). Taken together, our studies demonstrate that rather than a passive barrier, the urothelium is a
metabolically active cell layer, that uses iron biology to detoxify hematuria and defend itself from UTI.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
621889815
UEI
QHF5ZZ114M72
Project Start Date
24-September-2014
Project End Date
14-March-2025
Budget Start Date
01-August-2024
Budget End Date
31-July-2025
Project Funding Information for 2024
Total Funding
$243,194
Direct Costs
$160,708
Indirect Costs
$82,486
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Diabetes and Digestive and Kidney Diseases
$243,194
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5U54DK104309-11 8291
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5U54DK104309-11 8291
Patents
No Patents information available for 5U54DK104309-11 8291
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5U54DK104309-11 8291
Clinical Studies
No Clinical Studies information available for 5U54DK104309-11 8291
News and More
Related News Releases
No news release information available for 5U54DK104309-11 8291
History
No Historical information available for 5U54DK104309-11 8291
Similar Projects
No Similar Projects information available for 5U54DK104309-11 8291